Major pharmaceutical companies employ indirect marketing to promote weight-loss drugs in China amidst strict regulations. Analysts project the GLP-1 therapy market could reach $4 billion within five t
Asian stocks are poised to decline following a US chipmaker selloff, while crude oil prices rose amid Middle East tensions. Pharmaceutical leaders Merck and Eli Lilly announced regulatory approvals an
Eli Lilly announced an additional $4.5 billion investment across two Indiana manufacturing sites to expand production of genetic medicines and oral weight-loss drugs. Total U.S. capital expansion comm
A new peptide-drug conjugate activating five metabolic receptors demonstrated potent obesity and diabetes treatment in mice. Eli Lilly-funded researchers plan to present preclinical data on this quint
ChemBrief